First Foundation Advisors Edwards Lifesciences Corp Transaction History

First Foundation Advisors

  • $2.62 Billion
  • Q3 2025

A detailed history of First Foundation Advisors transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, First Foundation Advisors holds 39,678 shares of EW stock, worth $3.42 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
39,678
Previous 39,207 1.2%
Holding current value
$3.42 Million
Previous $3.07 Million 0.62%
% of portfolio
0.12%
Previous 0.12%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$73.75 - $81.83 $34,736 - $38,541
471 Added 1.2%
39,678 $3.09 Million
Q2 2025

Aug 13, 2025
BUY
$67.07 - $78.22 $60,698 - $70,789
905 Added 2.36%
39,207 $3.07 Million
Q1 2025

May 07, 2025
SELL
$67.95 - $76.19 $135,832 - $152,303
-1,999 Reduced 4.96%
38,302 $2.78 Million
Q4 2024

Feb 13, 2025
SELL
$64.54 - $75.92 $40,402 - $47,525
-626 Reduced 1.53%
40,301 $2.98 Million
Q3 2024

Nov 13, 2024
BUY
$59.7 - $93.78 $1.88 Million - $2.96 Million
31,547 Added 336.32%
40,927 $2.7 Million
Q2 2024

Aug 06, 2024
BUY
$84.3 - $94.31 $790,734 - $884,627
9,380 New
9,380 $866,000
Q4 2023

Feb 14, 2024
SELL
$61.71 - $77.76 $229,129 - $288,722
-3,713 Reduced 29.42%
8,909 $679,000
Q3 2023

Nov 15, 2023
SELL
$69.28 - $93.38 $1.17 Million - $1.57 Million
-16,852 Reduced 57.18%
12,622 $874,000
Q2 2023

Aug 14, 2023
SELL
$81.41 - $94.33 $14.8 Million - $17.1 Million
-181,642 Reduced 86.04%
29,474 $2.78 Million
Q1 2023

May 12, 2023
SELL
$74.26 - $84.51 $245,280 - $279,136
-3,303 Reduced 1.54%
211,116 $17.5 Million
Q4 2022

Feb 14, 2023
BUY
$68.3 - $87.44 $2.46 Million - $3.15 Million
36,046 Added 20.21%
214,419 $16 Million
Q3 2022

Nov 10, 2022
BUY
$82.37 - $107.29 $11.3 Million - $14.8 Million
137,744 Added 339.03%
178,373 $14.7 Million
Q3 2022

Nov 10, 2022
BUY
$82.37 - $107.29 $11.3 Million - $14.8 Million
137,744 Added 339.03%
178,373 $14.7 Million
Q2 2022

Aug 12, 2022
BUY
$86.5 - $128.27 $570,035 - $845,299
6,590 Added 19.36%
40,629 $3.86 Million
Q1 2022

May 05, 2022
SELL
$101.96 - $128.34 $3.09 Million - $3.89 Million
-30,295 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$106.37 - $130.68 $3.22 Million - $3.96 Million
30,295 New
30,295 $3.93 Million
Q3 2021

Nov 15, 2021
BUY
$102.91 - $122.75 $353,392 - $421,523
3,434 Added 13.73%
28,450 $3.22 Million
Q2 2021

Aug 13, 2021
BUY
$83.84 - $104.76 $214,295 - $267,766
2,556 Added 11.38%
25,016 $2.59 Million
Q1 2021

May 18, 2021
BUY
$78.68 - $90.67 $267,354 - $308,096
3,398 Added 17.83%
22,460 $1.88 Million
Q4 2020

Feb 16, 2021
BUY
$71.69 - $91.23 $397,234 - $505,505
5,541 Added 40.98%
19,062 $1.74 Million
Q3 2020

Nov 12, 2020
BUY
$67.19 - $87.44 $84,793 - $110,349
1,262 Added 10.29%
13,521 $1.08 Million
Q2 2020

Aug 14, 2020
BUY
$57.54 - $76.95 $504,683 - $674,928
8,771 Added 251.46%
12,259 $847,000
Q1 2020

May 11, 2020
SELL
$52.41 - $81.0 $64,516 - $99,711
-1,231 Reduced 26.09%
3,488 $658,000
Q4 2019

Feb 11, 2020
BUY
$71.7 - $82.09 $5,592 - $6,403
78 Added 1.68%
4,719 $1.1 Million
Q3 2019

Nov 12, 2019
SELL
$61.55 - $75.43 $125,500 - $153,801
-2,039 Reduced 30.52%
4,641 $1.02 Million
Q2 2019

Aug 14, 2019
BUY
$55.74 - $64.41 $271,398 - $313,612
4,869 Added 268.86%
6,680 $1.23 Million
Q1 2019

May 13, 2019
SELL
$47.89 - $64.05 $354,817 - $474,546
-7,409 Reduced 80.36%
1,811 $346,000
Q4 2018

Feb 14, 2019
BUY
$46.41 - $56.94 $349,977 - $429,384
7,541 Added 449.14%
9,220 $1.41 Million
Q3 2018

Nov 13, 2018
SELL
$45.7 - $58.03 $76,730 - $97,432
-1,679 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$42.45 - $51.3 $1,061 - $1,282
-25 Reduced 1.47%
1,679 $244,000
Q1 2018

May 15, 2018
SELL
$37.19 - $47.45 $6,285 - $8,019
-169 Reduced 9.02%
1,704 $238,000
Q4 2017

Feb 14, 2018
BUY
$33.79 - $39.39 $63,288 - $73,777
1,873
1,873 $211,000

Others Institutions Holding EW

# of Institutions
1,459
Shares Held
467M
Call Options Held
3.46M
Put Options Held
4.07M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track First Foundation Advisors Portfolio

Follow First Foundation Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email